Regionally focused UK private capital manager with ~£2B AUM, investing predominantly outside London in deep tech, life sciences, and enterprise software. Combines direct balance sheet investments with third-party fund management.
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.